A study to assess the safety and tolerability of adavosertib for patients with advanced solid tumours

Trial Identifier: D601HC00009
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04949425
Start Date: September 2021
Primary Completion Date: April 2022
Study Completion Date: April 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
English (UK) Translation
Spanish (Spain) Translation
Spanish (US) Translation

Trial Locations

Country Location
GB Manchester, GB, M20 4BX
US, TX Dallas, TX, US, 75230